These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6845862)

  • 1. [Long-term treatment of coronary heart disease with concomitant hypertension. Oxycardin retard in the coronary hypertensive patient].
    Tuluweit K; Strauss G
    ZFA (Stuttgart); 1983 Mar; 59(7):388-94. PubMed ID: 6845862
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of coronary heart disease. Oxycardin retard in simultaneously existing arterial hypertension].
    Hoffmann J
    Fortschr Med; 1983 Apr; 101(16):764-7. PubMed ID: 6852752
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of coronary insufficiency. Comparative study on the effect of a nitro compound (isosorbidedinitrate), a beta sympatholytic (bupranolol) and a drug combination (oxycardin)].
    Philipp R; Kutscha W
    Med Welt; 1980 May; 31(21):817-20. PubMed ID: 7392937
    [No Abstract]   [Full Text] [Related]  

  • 4. [Isosorbide dinitrate and bupranolol in the therapy of coronary heart disease (author's transl)].
    Pascal N; Eggert R
    Arzneimittelforschung; 1978; 28(5):847-50. PubMed ID: 373775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term testing of a coronary therapeutic agent under general practice conditions].
    Pascal N
    Med Welt; 1978 Apr; 29(15):635-40. PubMed ID: 417229
    [No Abstract]   [Full Text] [Related]  

  • 6. [Patient compliance with a free and fixed combination of isosorbide dinitrate and bupranolol].
    Gill E; Bechler M; Forst HT
    ZFA (Stuttgart); 1980 May; 56(14):1037-44. PubMed ID: 7415470
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experiences with isosorbide dinitrate in combination with a beta receptor blockader (Bupranolol)].
    Bernat AC; Riera de Barcia L
    Med Monatsschr; 1976 Oct; 30(10):470-3. PubMed ID: 10516
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long-term tolerance and effect of isosorbide-5-mononitrate in comparison to isosorbide dinitrate (ISDN retard) in patients with coronary disease].
    Smolarz A; Seeliger S; Glocke M
    Med Welt; 1981 Apr; 32(14A):548-53. PubMed ID: 6787385
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of Iso Mack Retard in the treatment of coronary disease].
    Zminkowska U; Markiewicz M
    Wiad Lek; 1984 Apr; 37(7):496-500. PubMed ID: 6385487
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination therapy with isosorbide dinitrate and verapamil in patients with coronary heart disease and hypertension: effect on blood pressure, ischemia and left ventricular function].
    Vogler AC; Silber S; Vogel M; Theisen K
    Z Kardiol; 1989; 78 Suppl 2():183-7; discussion 188-9. PubMed ID: 2588761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experiences with the Kö 1366 (Bunitrololhydrochloride) beta receptor blockader and the combination Kö 1366/Isosorbitdinitrate in patients with coronary disease].
    Holzhey P
    Wien Med Wochenschr; 1975 Oct; 125(42-44):624-9. PubMed ID: 5819
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of 50 mg isosorbide-5-nitrate retard on the stress tolerance of patients with coronary heart disease].
    Eggeling T; Jansen W; Osterspey A; Tauchert M; Hilger HH
    Med Klin (Munich); 1986 Apr; 81(8):275-80. PubMed ID: 3785087
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug therapy of coronary heart disease with nitrisken retard].
    Kugler G; Welzel D; Schiess W
    Ther Ggw; 1982 Mar; 121(3):172-87. PubMed ID: 7046127
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemodynamic changes during treatment with isodinit, sectral, stenopril and kratemon].
    Stankusheva G; Draganov V; Manolov P
    Vutr Boles; 1987; 26(2):33-8. PubMed ID: 3604194
    [No Abstract]   [Full Text] [Related]  

  • 15. [Short-term and long-term therapy with slow-release ISDN. Echographic, vector cardiographic and ergometric findings (author's transl)].
    Mengden HJ; Just H; Giesecke J
    MMW Munch Med Wochenschr; 1978 Aug; 120(34):1085-90. PubMed ID: 308160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined treatment of coronary heart disease with diltiazem and isosorbide dinitrate].
    Beythien RD
    Dtsch Med Wochenschr; 1983 Feb; 108(5):176-80. PubMed ID: 6402353
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of IS-5-MN in coronary disease. Monocentric double-blind crossover comparison with ISDN retard and placebo].
    Müller G; Schmidt-Voigt J
    Med Welt; 1981 Apr; 32(14A):554-6. PubMed ID: 7242319
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of isonit (nitrosorbide) in the treatment of ischemic heart disease].
    Zamotaev IP; Venediktova MG; Lozinskiĭ LG; Sandomirskiĭ BL
    Klin Med (Mosk); 1986 Jun; 64(6):28-33. PubMed ID: 3747432
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of ischemic heart disease with beta-receptor blockers and isosorbide dinitrate (author's transl)].
    Wermuth G
    MMW Munch Med Wochenschr; 1975 Oct; 117(40):1613-4. PubMed ID: 241932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isosorbide dinitrate in coronary heart disease. Effects of a delayed-action preparation during acute load and in chronic use].
    Westermann KW; Eggert R; Kugler G; Priester G
    Med Klin; 1975 Aug; 70(35):1375-9. PubMed ID: 1177792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.